Table 14.
Recommendations for teriparatide therapy.
| Recommendations | Grading of recommendations | Quality of evidence |
|---|---|---|
| Initial treatment for patients at very high fracture riska | I | A |
| Treatment for 1–2 years then, followed by antiresorptive drug | I | B |
| May consider in patients with inadequate response to bisphosphonates despite good adherence for ≥ 2 years | IIa | B |
For reduction of vertebral and nonvertebral fracture.